Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024
The live webcast will be held on Thursday, January 4, 2024, starting at 1:30 p.m. PT / 4:30 p.m.
- The live webcast will be held on Thursday, January 4, 2024, starting at 1:30 p.m. PT / 4:30 p.m.
- ET featuring presentations by members of Sutro’s senior management team and external key opinion leaders in oncology; and concluding with a Q&A session.
- To access the live audio webcast on Thursday, January 4, at 1:30 p.m. PT / 4:30 p.m.
- ET, please go to https://ir.sutrobio.com/news-events/ir-calendar
An archived replay of the webcast will be available on the Company’s website following the live presentation.